Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Harlan A. Pinto, MD
Stanford University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pretoria Academic Hospital
Pretoria, South Africa
- Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
- Stanford University Medical Center
Stanford, California, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Veterans Affairs Medical Center - Atlanta (decatur)
Decatur, Georgia, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Chicago (lakeside)
Chicago, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Ccop - Ann Arbor Regional
Ann Arbor, Michigan, United States
- Ccop - Duluth
Duluth, Minnesota, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Veterans Affairs Medical Center - East Orange
East Orange, New Jersey, United States
- Ccop - Northern New Jersey
Hackensack, New Jersey, United States
- University of Rochester Cancer Center
Rochester, New York, United States
- Albert Einstein Comprehensive Cancer Center
The Bronx, New York, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Hahnemann University Hospital
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
- Vanderbilt Cancer Center
Nashville, Tennessee, United States
- Veterans Affairs Medical Center - Nashville
Nashville, Tennessee, United States
- University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, United States
- Veterans Affairs Medical Center - Madison
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 May 1995
- Primary completion
- 31 May 2002
- Completion
- —
- Last update posted
- 15 Jun 2023
- Registered enrollment
- 32
- Registry id
- NCT00002632
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.